Identification and characterization of novel tumor-associated proteins as potential tumor markers for diagnosis and therapy

RM Grifantini - 2014 - amsdottorato.unibo.it
This study deals with the discovery and characterization of EXN6 and EXN11 as novel tumor-
associated proteins. EXN6 is mainly present in breast and ovary cancers (40 and 35%) …

A novel potential cancer marker and therapeutic target

M Parri, S Campagnoli, A Grandi, ED Camilli, V Farini… - Cancer Research, 2014 - AACR
In our recent research activities, we identified 89 novel candidate markers for prevalent
cancers by a systematic Tissue microarray analysis (TMA) of a large collection of polyclonal …

A novel cancer marker and potential therapeutic target

M Parri, S Campagnoli, A Grandi, A Santi, E De Camilli… - cell, 2014 - ejcancer.com
In our recent research activities, we identified 89 novel candidate markers for prevalent
cancers by a systematic Tissue Microarray analysis (TMA) of a large collection of polyclonal …

A novel protein is lower expressed in renal cell carcinoma

R Guan, Y Xu, H Lei, Z Gao, Z Xin, Y Guo - International journal of …, 2014 - mdpi.com
Engrailed-2 (EN2) has been identified as a candidate oncogene in breast cancer and
prostate cancer. It is usually recognized as a mainly nuclear staining in the cells. However …

Abstract 4384A: A novel potential therapeutic target for breast, lung, ovary and colon cancer

M Parri, A Grandi, S Campagnoli, E De Camilli, A Santi… - Cancer Research, 2015 - AACR
We identified 89 novel candidate markers for prevalent cancers by a systematic Tissue
microarray analysis (TMA) of a large collection of polyclonal antibodies (approximately …

AB80. A novel protein is lower expressed in renal cell carcinoma

R Guan, Y Xu, H Lei, Z Gao, Z Xin… - … Andrology and Urology, 2014 - ncbi.nlm.nih.gov
Abstract Engrailed-2 (EN2) has been identified as a candidate oncogene in breast cancer
and prostate cancer. It is usually recognized as a mainly nuclear staining in the cells …

[PDF][PDF] The expression of UNC5D is abnormal in the early stage of colorectal tumors associated with its proliferation and migration.

LP Shi, C Zou, LJ Mao, TT Chen… - European Review for …, 2024 - europeanreview.org
OBJECTIVE: Colorectal adenomas are an important precancerous lesion of colorectal
adenoma with a high incidence. This study aims to explore new prognostic targets for …

Engrailed-2 (EN2) expression in ovarian cancer.

SE McGrath - 2015 - openresearch.surrey.ac.uk
Epithelial ovarian cancer (EOC) is a common malignancy, usually diagnosed at an
advanced stage, resulting in over 4,000 deaths each year in the UK. There is currently no …

EXOSC5 as a novel prognostic marker promotes proliferation of colorectal cancer via activating the ERK and AKT pathways

H Pan, J Pan, S Song, L Ji, H Lv, Z Yang - Frontiers in oncology, 2019 - frontiersin.org
Background and Objective: Exosome component 5 (EXOSC5) is a novel cancer-related
gene that is aberrantly expressed in various malignances. However, the molecular …

Engrailed-2 (EN2)–a novel biomarker in epithelial ovarian cancer

SE McGrath, N Annels, TK Madhuri, A Tailor… - BMC cancer, 2018 - Springer
Background Epithelial ovarian cancer is a common malignancy, with no clinically approved
diagnostic biomarker. Engrailed-2 (EN2) is a homeodomain-containing transcription factor …